ATP is an important neuronal and astroglial signaling molecule in the brain. In the present study, brain slices were prepared from the prefrontal cortex (PFC) of Wistar rats and 2 lines of mice. P2X 7 receptor immunoreactivity was colocalized with astro-and microglial but not neuronal markers. Whole-cell patch-clamp recordings showed that, in astroglial cells, dibenzoyl-ATP (BzATP) and ATP caused inward currents, near the resting membrane potential. The inactivity of a,b-methylene ATP, as well as the potency increases of BzATP and ATP in a low divalent cation (X 21 )--containing superfusion medium suggested the involvement of P2X 7 receptors. This idea was corroborated by the inhibition of these current responses by PPADS, Brilliant Blue G, A 438079, and calmidazolium. Ivermectin, trinitrophenyl-adenosine-5#-triphosphate, and cyclopentyldipropylxanthine did not alter the agonist effects. The reversal potential of BzATP was near 0 mV, indicating the opening of cationic receptor channels. In a low X 21 superfusion medium, ATP-induced current responses in PFC astroglial cells of wild-type mice but not of the P2X 7 knockouts. Hence, cortical astroglia of rats and mice possess functional P2X 7 receptors. These receptors may participate in necrotic/apoptotic or proliferative reactions after stimulation by large quantities of ATP released by central nervous system injury.
Introduction
ATP is an important bidirectional signaling molecule in the brain subserving neuron--astroglia interactions (Volterra and Meldolesi 2005; Fields and Burnstock 2006) . This nucleotide may be released from nerve terminals/glial cells by exocytotic mechanisms (Burnstock 2006) or only from astroglial cells via connexin hemichannels, volume-regulated anion channels, ATP-binding cassette transporters, and the cystic fibrosis transmembrane regulator; alternatively, ATP may leak through the damaged neuronal/glial plasma membrane after any type of brain injury (Illes and Alexandre Ribeiro 2004; Haydon and Carmignoto 2006) . Astroglial cells are endowed with ATPsensitive receptors of the P2X (ligand-gated cationic channels) and P2Y (G protein--coupled receptors) types (Verkhratsky and Steinha¨user 2000; Abbracchio and Ceruti 2006) . P2X 7 receptors have been identified both at peripheral and central immunocytes such as macrophages, lymphocytes, and microglia, where they interact with several partners including cytoskeletal proteins (Sperla´gh et al. 2006; Surprenant and North 2009 ). P2X 7 receptors are stimulated by high extracellular concentrations of ATP and are involved in both apoptosis/ necrosis and proliferation of immunocompetent cells (Duan and Neary 2006) . Brain injury may inflict an imminent damage to neurons and astroglia via the massive outflow of ATP and the subsequent activation of P2X 7 receptors (Franke and Illes 2006) . Moreover, on a more protracted timescale, the overt proliferation of astroglia induced by this receptor may hinder the neuronal regeneration, for example, in the penumbra surrounding the ischemically damaged infarct area.
Cultured astroglial cells from rats and mice have been reported to possess functional P2X 7 receptors (Duan et al. 2003; Suadicani et al. 2006; No¨renberg et al. 2010) , although enhanced green fluorescent protein--expressing astroglia acutely dissociated from the cortex of the transgenic Tg(GFAP/EGFP) mice exhibited ATP-induced currents, which were mediated by P2X 1/5 heteromeric receptors (Lalo et al. 2008) . Moreover, in brain slice preparations, where the functional integrity of the astroglial network and the neuronal--astroglial synaptic connections have been preserved rather equivocal results were obtained. In the hippocampus (Jabs et al. 2007) or cerebral cortex (Lalo et al. 2008) of Tg(GFAP/ EGFP) mice, there were either no or unpredictable and nonreproducible responses to high concentrations of ATP. By contrast, in hippocampal brain slices of rats, ATP appeared to activate P2X 7 receptors at astroglial cells causing the release of glutamate, which in turn activated a tonic current in CA1 pyramidal neurons (Fellin et al. 2006) .
The aim of the present study was to clarify these apparent contradictions, by comparing the dibenzoyl-ATP (BzATP) and ATP-induced inward currents in astroglial cells located in brain slices of the prefrontal cortex (PFC) prepared from rats and mice. Both agonists appeared to produce P2X 7 receptor--mediated currents in rats. By contrast, ATP had a pronounced effect in wild-type mice, only a slight effect in Tg(GFAP/EGFP) mice, and no effect at all in the P2X 7 knockouts. Moreover, P2X 7 receptor activation failed to produce current responses in layer V pyramidal neurons or to inhibit excitatory postsynaptic currents (EPSCs) evoked by the stimulation of glutamatergic afferents synapsing onto these neurons, excluding a major astroglia--neuron cross talk via this receptor.
Materials and Methods

Experimental Animals
Most experiments were performed in Wistar rats (own breed; 10--13 days old). In addition, knockout and transgenic mice of the same age were also used, such as genetically deficient B6.129P2-P2rx7 tm1Gab /J (P2X 7 -/-) mice and their wild-type (C57BL/6J) counterparts, as well as transgenic mice overexpressing enhanced green fluorescent protein under the control of the astroglia-specific glial fibrillary acidic protein promoter FVB/N-Tg(GFAPGFP)14Mes/J and the corresponding FVB/NJ wild-type animals (all purchased from The Jackson Laboratory).
Brain Slice Preparation, Whole-Cell Patch-Clamp Recordings, and Drug Application Protocols Coronal brain slices containing the prelimbic portion of the medial PFC were prepared as described previously (Wirkner et al. 2007 ). Pyramidal cells and astroglia in layer V of the PFC were visualized with an upright microscope, equipped with an infrared filter, differential interference contrast (DIC) optics, and a 340 water immersion objective (Axioscope FS; Carl Zeiss). Astroglial cells of the Tg(GFAP/EGFP) mice were identified by fluorescence microscopy. In some experiments, hippocampal slices of rats were prepared by procedures similar to those described for the PFC (Wirkner et al. 2007 ). Astroglial cells were identified in the oriens layer in close apposition to the CA1 layer ( <200 lm distance).
Patch pipettes were filled with intracellular solution of the following composition (in mM): K-gluconic acid 140, NaCl 10, MgCl 2 1, N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid (HEPES) 10, EGTA 11, Mg-ATP 1.5, and Li-GTP 0.3; pH 7.2 adjusted with KOH (~305 mosmol/L). Pipette resistances were in the range of 5--7 MX. Brain slices were superfused with HEPES-based, oxygenated artificial cerebrospinal solution (aCSF) consisting of (in mM): NaCl 135, KCl 5, MgCl 2 2, CaCl 2 2, HEPES 10, and glucose 11. To create low divalent cation (X 2+ ) conditions, MgCl 2 was omitted from the medium and the CaCl 2 concentration was decreased to 0.5 mM.
The membrane potential of all cells was measured in the currentclamp mode of the patch-clamp amplifier (Multiclamp 700A; Molecular Devices) immediately after establishing whole-cell access. Then, the system was left for 5--10 min to allow for settling of a diffusion equilibrium between the patch pipette and the cell interior, before a current-step protocol (14 increasing steps of 50--150 pA, depending on the membrane resistance) was applied. Subsequently, the holding potential was set to --80 mV in the voltage-clamp mode of the amplifier and voltage-step protocols in the range of --80 to +35 mV for pyramidal neurons (5 mV steps) and in the range of --160 to +70 mV for astroglial cells (10 mV steps) were used.
Step duration was 500 ms, and steps were delivered with an interval of 2 s. Cells, where the access resistance (R a ) values were higher than 25 MX or varied by more than 20% during the experiment were discarded. Multiclamp and pClamp software (Molecular Devices) were continuously used to store the recorded data to perform offline analysis/ filtering and to trigger the fast drug application system used.
Excised patches were prepared by slowly withdrawing the pipette and thereby separate the excised patch from the surrounding cells. We cannot rule out that in some of the recordings most of the whole astroglial cell body remained stuck to the recording pipette after being separated from its processes.
All compounds were applied locally by pressure by means of a computer-controlled DAD12 superfusion system (Adams and List). The drug application tip touched the surface of the brain slice and was placed 100--150 lm from the patched cell. The observation of the ejection of Lucifer Yellow (LY)--containing aCSF from the application tip by fluorescence optics confirmed that the area superfused by medium had a maximum diameter of about 600--800 lm.
Concentration/response curves were fitted using the Hill equation
where I is the peak current produced by the agonist, I max is the maximal current at saturating agonist concentration, nH is the Hill slope value, and EC 50 is the concentration of agonist needed to produce 50% of I max .
Electrical Stimulation
A coaxial stainless steel electrode was placed on layer I/II to evoke EPSCs at a holding potential of --70 mV in pyramidal neurons of the PFC layer V. Rectangular pulses (0.1 ms duration, 4--15 V intensity) were delivered, every 30 s. The stimulation voltage was chosen by increasing it to a value evoking just submaximal EPSCs by means of a Grass SD9 stimulator (Grass Technologies) . In some of the experiments, brain slices were incubated with fluorocitric acid (100 current-clamp mode lM) containing medium for 2 h and were then superfused in the organ bath with fluorocitric acid-free aCSF.
Immunofluorescence, LY Filling of Astroglia, and Confocal Microscopy In most experiments, rats and mice were transcardially perfused under thiopental sodium anesthesia with paraformaldehyde (2%) in sodium acetate buffer (pH 6.5) followed by paraformaldehyde (2%) in sodium borate buffer (pH 8.5) (Franke et al. 2004) . Then, the brains were removed, stored overnight, and coronal sections of their prefrontal cortices were prepared. In some cases, patch pipettes filled with an LY (200 lM)--containing intracellular solution were used to record for 15--40 min from cortical slices of untreated animals. These preparations were subsequently used for immunohistochemistry. The brain slices from transcardially perfused brains were incubated with an antibody mixture of mouse anti-GFAP (glial fibrillary acidic protein, 1:1000; Sigma), mouse anti-S100 (S100 Protein Ab-1, Clone 4C4.9, 1:600; Dianova), or with biotinylated GSA-B4 (Griffonia simplicifolia agglutinin isolectin B4, 1:300; Sigma) and rabbit anti-P2X 7 (1:600; Alomone Labs) together with 0.3% Triton X-100 and 5% fetal calf serum in Tris-buffered saline for 48 h at 4°C. For the simultaneous visualization of the 2 primary antisera, a mixture of Cy2-conjugated donkey anti-mouse IgG (1:400) and Cy3-conjugated donkey anti-rabbit (1:1000; Jackson ImmunoResearch, each) or for GSA-B4-incubation Cy2-conjugated streptavidin (1:300; Jackson ImmunoResearch) were used, respectively. By contrast, in the brain slices with LY-filled cells, a mixture of Cy5-conjugated donkey antimouse IgG (1:100) and Cy3-conjugated donkey anti-rabbit (1:1000) or for GSA-B4-incubation Cy5-conjugated streptavidin (1:100) were used, respectively. Sections were then stained with Hoechst 33342 (1:1000; Molecular Probes) for 5 min. For the characterization of NG2 chondroitin sulphate proteoglycan (NG2) expression, the primary antibodies goat anti-GFAP (1:300; Santa Cruz Biotechnology, Inc.), rabbit anti-S100 (1:500; Swant), and monoclonal mouse anti-NG2 (1: 500; Milipore) were used as well as the Cy5-conjugated donkey anti-goat IgG (1:100), Cy3-conjugated donkey anti-mouse (1:1000), and Cy2 conjugated donkey anti-rabbit (1:400). The double labeling of GFAP and S100 was performed by using mouse anti-GFAP (Sigma) and rabbit anti-S100 (Swant).
Control experiments were performed without all primary antibodies or by preadsorption of the antibody with the immunizing peptides. The double and triple immunofluorescence were investigated by a confocal laser scanning microscope (LSM 510 Meta, Zeiss) using excitation wavelengths of 633 nm (helium/neon2, blue Cy5-labeling), 543 nm (helium/neon1, red Cy3-immunofluorescence), and 488 nm (argon, yellow--green Cy2-immunofluorescence).
Materials
All drugs were purchased from Sigma-Aldrich with the exception of pyridoxalphosphate-6-azophenyl-2#,4#-disulfonic acid tetrasodium salt (PPADS) and 3-[[5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl]methyl]pyridine hydrochloride (A 438079) which were obtained from TocrisBiotrend. The pH value of the ATP-containing aCSF superfused onto the astroglial cells was adjusted by NaOH to 7.4.
Statistics
Means ± standard error of the mean are given throughout. SigmaPlot Version 9.01 integrated with SigmaStat Version 3.10 (Jandel Scientific) was used for all statistical evaluations. Data related to agonist/ antagonist application were compared with controls using the t-test or the Mann--Whitney rank sum test, as appropriate. Multiple comparisons between data describing agonist effects in different cells were performed by one-way analysis of variance followed by the Dunn's test. In all cases, a probability level of 0.05 or less was considered to be statistically significant. Supplementary  Fig. 1A ). Astroglial cells had smaller diameters (~7 lm) than pyramidal neurons (~15 lm). In a second approach, the diffusion of LY-containing intracellular solution via the patch pipette into these cells allowed their rough identification by fluorescence microscopy ( Supplementary Fig. 1B) . Typically, dense processes extending several tens of micrometers surrounded the cell somata. In most of the recordings, only one astroglial cell was labeled with LY (78 of the total number of 81; Supplementary Fig. 1Ba ); in the residual preparations, the fluorescence dye diffused also into neighboring glial cells ( Supplementary Fig. 1Bb ). By altering the focus of the microscope optics, a number of glial cells could be observed, which were distributed around the patched astroglial cells in different focal planes. It has to be noted, however, that a missing dye-coupling does not exclude the existence of low resistance pathways between neighboring astroglia because, for example, connexin 43 junctions may either be dye permeable or dye impermeable (Heyman and Burt 2008) .
In most experiments, we patched successively an astroglial cell and a nearby pyramidal neuron, in order to elucidate the exact localization of LY-labeled astroglial cells for postembedding immunohistochemistry ( Supplementary Fig. 1Bc ). We also electrophysiologically characterized the astroglial cells, by injecting in the current-clamp mode of the amplifier a series of depolarizing current steps ( Supplementary Fig. 1C ). Whereas pyramidal neurons fired action potentials already following relatively modest depolarizations ( Supplementary Fig. 1Cb ), astroglial cells never responded with action potentials to depolarizing current injection ( Supplementary Fig. 1Ca ). In addition, the resting membrane potential of these cells (--81.0 ± 0.5 mV; n = 322) was considerably higher than that of the pyramidal neurons (--69.1 ± 1.6 mV; n = 83). Postembedding immunohistochemistry demonstrated staining for the astroglial markers GFAP ( Supplementary Fig. 1Da ,b) and S100 (the antibody has been described by the supplier to preferentially label S100b; Supplementary Fig. 1Dc,d ) of the LY-labeled and functionally characterized cells. By contrast, the microglial marker GSA-B4 never stained the LY-labeled astroglial cells ( Supplementary Fig. 1Df ), although GSA-B4-immunopositive microglia were present in the investigated brain slices ( Supplementary Fig. 1De ). There was no coexpression of labeling with NG2, a marker of oligodendrocyte precursor cells, with S100 or GFAP in the investigated cortical area of rats ( Supplementary Fig. 1Ea--d) . Microglial cells in brain slices may exhibit morphological characteristics somewhat similar to astroglia after LY filling and also fail to fire action potentials in response to depolarizing current injection (Brockhaus et al. 1993; Boucsein et al. 2000) . However, in voltage-clamp recordings, resting microglia express a typical inwardly rectifying current pattern and acquire an additional outwardly rectifying current component only after cell activation, for example, following facial nerve axotomy (Boucsein et al. 2000) . Thus, immunohistochemistry in conjunction with voltageclamp recordings (see below) allowed the distinction of astroglial cells from microglia.
After having identified the patched cells as astroglia, we searched for the presence of P2X 7 immunoreactivity (IR). In fact, this receptor subtype was found on S100-positive cells. An example for the coexpression of P2X 7 receptors with S100 immunopositivity is documented in Figure 1Aa --c. Using the more specific antibody GFAP for the characterization of fibrous astroglia, P2X 7 /GFAP coexpression was also found (Fig. 1Ca--c) . For a better understanding of the cellular expression of these glial cell markers in the PFC, we treated the brain slices with an antibody mixture of GFAP and S100 to investigate their coexpression on the same cell. Under these conditions, the S100 and GFAP immunopositivities were largely overlapping (Fig. 1Ba,b) .
In contrast to astroglial cells, LY-filled neurons were not immunoreactive for P2X 7 receptors, although P2X 7 immunopositive structures were found in the vicinity of the neurons (Fig. 1D,b) ; for the colocalization of P2X 7 and GFAP on LY-filled astroglia, consult Figure 5Ca --d. Double staining with the microglial marker GSA-B4 indicated a clear colocalization of P2X 7 receptors on GSA-B4-positive microglial cells (Fig. 1Ea,b) . GSA-B4-immunopositive cells without P2X 7 receptor expression were also found ( Fig. 1Eb ).
In the PFC of P2X 7 -/-mice, the receptor IR was only slightly above background (Fig. 1Fa ,b) and could be abolished by the immunizing peptide, whereas the corresponding wild-type mice exhibited a clear P2X 7 IR on GFAP-IR astroglia ( Fig. 1Ga,b ; but see Sim et al. 2004 ). (Fig. 6Aa) . We determined the membrane potential (V m ), membrane capacitance (C m ), and membrane resistance (R m ) of some ORAs (Supplementary Table 1 ). Whereas the V m of the VRAs and PAs, as well as their C m values did not differ in a statistically significant manner from those of the ORAs, the R m values were considerably lower. This might have been due to prominent intercellular coupling of the VRAs and especially the PAs to neighboring glia, however, the passively rectifying properties were reported to have in no way a predictive value in this respect; passive cells were detected also after pretreatment with gap junction inhibitors, and current profiles of isolated membrane patches closely resembled those obtained in the whole-cell configuration . Previously glutamate transporter currents were reported to exist only in VRAs, whereas the AMPA receptor current density was much higher in ORAs than in VRAs; c-aminobutyric acid A currents were of comparable density in both types of astroglial cells (Zhou and Kimelberg 2001) .
Submaximal concentrations of N-methyl-D-aspartate (NMDA; 100 lM) and BzATP (300 lM) were applied to all 3 types of astroglial cells at a holding potential of --80 mV (Figs 2 and 3Bc,Cc). Whereas the currents evoked by BzATP reached a maximum within this application period, those induced by NMDA failed to do so. Since NMDA was used only as a positive control, we standardized the drug superfusion time at 10 s for all agonists. Both NMDA and BzATP were found to cause smaller current responses in ORAs (--86.9 ± 23.2 pA, n = 7 and --172.0 ± 40.2 pA, n = 5, respectively; P < 0.05 each) (Fig. 2Ac,d ) than in VRAs (--413.5 ± 55.4 pA, n = 52 and --566.9 ± 44.0 pA, n = 32, respectively) ( Fig. 2Bc,d ) and PAs (-537.1 ± 136.0 pA, n = 15, and --442.8 ± 51.0 pA, n = 13, respectively) ( Fig. 2Cc,d ). In addition, the calculated current densities for NMDA and BzATP indicated a similar trend, excluding the possibility that the size of the astroglial cells is responsible for the above phenomenon (Fig. 2Ad ,Bd,Cd). However, since the great majority of the cells belonged to the VRA and PA classes, we decided to pool all data, especially because in subsequent experiments, the variability of the current amplitudes was rather modest and in many cases the data were normalized. It is noteworthy that the activation (s on(10--90%) ; ORAs, 1670.0 ± 244.9 ms; VRAs, 1644.5 ± 264.2 ms; PAs, 1872.6 ± 283.1 ms; n = 5--6; P > 0.05) Figure 1 . Confocal images of multiple immunofluorescence labeling in slices of the rodent PFC. Rats (A--E) and mice (F, G) were either killed after perfusion fixation by decapitation, and their brains were immediately processed for immunohistochemistry, or brain slices were at first used for electrophysiological recordings, and immunohistochemical procedures were applied only thereafter (D, E). (Aa--c) P2X 7 receptor IR on S100-positive astroglia (arrow). In this and all subsequent panels, the Hoechst 33342-staining of cell nuclei is color-coded by blue. (Ba, b) Differences in the IR for GFAP and S100 in the same cell. Arrows indicate the double-labeled cells. (Ca--c) Coexpression of the P2X 7 receptor IR on a GFAP-positive cell (arrow). (Da, b) The electrophysiologically identified LY-labeled neuron exhibited no IR for P2X 7 receptors, although P2X 7 -positive structures were found in the vicinity of this neuron. In contrast to this finding, the colocalization of P2X 7 with S100 on a LY-labeled astroglia could be documented after electrophysiological recording (see Fig. 5Ca--d) . (Ea, b) Localization of P2X 7 IR on GSA-B4-positive microglial cells (arrow). Microglial cells without P2X 7 receptor labeling were also found. (Fa, b) Only low P2X 7 labeling was observed in the brain of P2X 7 À/À mice, and there was practically no colocalization with GFAP at astroglia. (Ga, b) Clear P2X 7 receptor expression at the astroglia of wild-type mice. The background P2X 7 staining is more pronounced than in the P2X 7 receptor--deficient mice, although these preparations were made under identical conditions. Scale bars for all panels 5 10 lm.
Cerebral Cortex April 2011, V 21 N 4 809 and deactivation time constants (s de ; ORAs, 1259.0 ± 324.7 ms; VRAs, 1063.6 ± 88.6 ms; PAs, 930.1 ± 56.1 ms; n = 4--7; P > 0.05) of the BzATP currents in the 3 types of astroglial cells did not differ from each other in a statistically significant manner.
Increasing concentrations of NMDA (10--1000 lM; Fig. 3Bc ) and BzATP (30--1000 lM; Fig. 3Cc ) were applied onto astroglial cells with similar protocols in a normal Ca 2+ /Mg 2+ -containing aCSF solution. Then, concentration--response curves were constructed for NMDA (I max = --1083 ± 90.8 pA, EC 50 = 112.7 ± 18.6 lM, n = 6--7) and BzATP (I max = --888.1 ± 106.2 pA, EC 50 = 311.5 ± 39.8 lM, n = 6--7). These data confirmed that the single concentrations of NMDA (100 lM) Figure 2 . Current--voltage characteristics of astroglial cells as well as current responses of these cells to NMDA and BzATP in brain slices of the rat PFC. The holding potential in the whole-cell mode of patch-clamp recordings was --80 mV. (Aa, Ba, Ca) Current responses to a series of voltage steps from --160 to þ70 mV (10 mV steps for 500 ms) were recorded from astroglial cells, which were classified according to 3 types of I/V patterns as (ORA; A), (VRA; B), and (PA; C). (Ab, Bb, Cb) Representative recordings from astroglial cells of the respective I/V patterns at the initial transients (filled circles) and at the final steady state (empty circles) of the elicited currents. (Ac, Bc, Cc) Current responses to NMDA (100 lM; black) and BzATP (300 lM, red) from astroglial cells caused by a 10-s rapid local application onto each cell type. (Ad, Bd, Cd) Comparison of the current amplitudes (left axis, pA) and the current densities (right axis, pA/pF) for all cells measured. The number of cells is indicated within the respective columns. *P \ 0.05; statistically significant differences from the corresponding values in VRAs and PAs.
and BzATP (300 lM) chosen for all experiments were in fact submaximal. Figure 3A demonstrates that a 10 s application time of BzATP (300 lM) was sufficient to reach the maximum inward current amplitude (n = 6). It also shows that application times of up to 120 s fail to induce biphasic inward currents, with an early rapid opening of cationic channels and a later massive conductance increase due to channel dilation (Chaumont and Khakh 2008; Yan et al. 2008) or pore formation via the involvement of pannexin hemichannels (Roger et al. 2008 ). P2X 7 receptors devoid of a pore-forming capability have been reported to occur in human Mu¨ller cells of the retina (Pannicke et al. 2000) and cultured hippocampal astroglial cells (Bianco et al. 2009 ).
Effects of ATP and Its Structural Analogues on Astroglial Cells of the Rat PFC, and Their Interaction with Receptor Type Selective Antagonists and Allosteric Modulators
Then, we attempted to characterize the subtype of the BzATP-sensitive putative P2X receptor (see reversal potential measurements in Fig. 5A ), by various P2 receptor agonists. The application of aCSF for 10 s and with a pressure similar to that used for agonist ejection did not cause any appreciable current response (7.4 ± 2.1 pA, n = 28; Fig. 3Ba,b) . Both NMDA (100 lM, --176.8 ± 27.2 pA, n = 30) and the P2X 1,7 agonist BzATP (300 lM, --574.4 ± 47.3 pA, n = 30) induced inward currents. In some of the experiments, a small outward current was caused by the P2X 1,3 agonist a,b-meATP (300 lM) or the general P2X receptor agonist ATP-c-S (300 lM), probably due to the activation of a potassium conductance (Fig. 3Ba) . However, in the mean of all measurements, the effects of the 2 agonist at 100 and 300 lM concentrations each were not statistically significant (Fig. 3Bb) . It is noteworthy that both structural analogues of ATP are rather resistant to degradation by ectoATPases. The endogenous agonist ATP caused at 3000 lM but not 300 lM a small inward current response (--25.2 ± 8.6 pA, n = 10, P < 0.05), which differed from the effect of aCSF (Fig. 3Ba,b) .
Because a distinguishing feature of P2X 7 receptors is their relatively low sensitivity to ATP and their 10--30 times higher sensitivity to BzATP (Sperla´gh et al. 2006) , we decided to construct complete concentration--response curves for ATP in the brain slice preparations (Fig. 3Cc) . In a normal Ca 2+ /Mg 2+ -containing aCSF, BzATP (EC 50 = 311.5 ± 39.8 lM, n = 6; see also above) was in fact considerably more potent than ATP itself (EC 50 = 10 801.1 ± 3680.2 lM, n = 7). Moreover, divalent cations were suggested to chelate the active form of ATP (ATP 4-) stimulating P2X 7 receptors or alternatively inhibit current flow through the receptor--channel complex (Sperla´gh et al. 2006) . Hence, in a low divalent cation (X 2+ )--containing aCSF, the concentration--response curves of BzATP (EC 50 = 159.5 ± 71.1 lM, n = 7) and ATP (EC 50 = 5383.7 ± 1842.9 lM, n = 6, P < 0.05 each) were markedly shifted to the left, when compared with the EC 50 values in a normal aCSF. At the same time, the I max values for BzATP (--888.1 ± 106.2 pA and --2777.0 ± 411.6 pA, respectively, n = 7) and ATP (--1150.4 ± 314.6 pA and --1923.8 ± 289.9 pA, respectively, n = 6--7; P < 0.05 each) also increased in comparison with those measured in a normal aCSF. The original tracings of the BzATP and ATP currents are shown in normal and low X 2+ aCSF, respectively, to document that the current responses always reached a clear maximum with both agonists and in both types of external medium (Fig. 3Ca,b) .
Thereafter, we investigated the interaction of ATP and BzATP with a range of P2X receptor-selective or preferential antagonists as well as with an allosteric modulator. For this purpose, the stability of the agonist-induced currents was investigated by applying the same concentration of BzATP (300 lM) 5 times with 5-min intervals in succession (S 1 to S 5 ). Under these conditions, the BzATP current amplitude decreased at S 3 to 77.1 ± 2.6% (n = 8, P < 0.05) of its original value at S 1 (Fig. 4Aa ,Ab,Ac). When the nonselective P2X/P2Y antagonist PPADS (30 lM) or the selective P2X 7 receptor antagonists Brilliant Blue G (BBG; 1 lM), A 438079 (1 lM), and calmidazolium (0.3 lM) were applied immediately after S 1 , the currents evoked by BzATP at S 3 decreased to 12.4 ± 4.2% (n = 6), 61.9 ± 3.0% (n = 6), 25.7 ± 5.3% (n = 8), and 65.7 ± 1.9% (n = 8, P < 0.05 each), respectively. By contrast, the allosteric modulator of P2X 4 receptors, ivermectin (10 lM; n = 7), the P2X 1--4 receptor antagonist trinitrophenyl-adenosine-5#-triphosphate (TNP-ATP; 1 lM; n = 5), and the lower concentration of BBG (0.3 lM; P > 0.05 each) had no effect at all. For comparison, we demonstrate the strong potentiation of BzATP by a low X 2+ aCSF solution (298.9 ± 30.5%, n = 5, P < 0.05).
In order to find out whether the effect of ATP is modulated because of its enzymatic degradation to adenosine, which in turn may activate inhibitory A 1 adenosine receptors, we investigated the effect of the selective A 1 receptor antagonist cyclopentyl-dipropylxanthine (DPCPX; 0.1 lM; Fig. 4Bb,Bc) . In a normal, DPCPX-free aCSF solution, the current amplitudes evoked by ATP (3000 lM) did not appreciably decrease from S 1 to S 3 (91.6 ± 11.1%, n = 3, P > 0.05). In separate experiments, a 10-min superfusion with DPCPX also failed to alter the effect of ATP (84.1 ± 9.2%, n = 5, P > 0.05 vs. controls). Thus, adenosine generated by the enzymatic breakdown of ATP does not appear to depress the P2X 7 receptor currents in a DPCPX antagonizable manner. In accordance with previous experiments, a low X 2+ aCSF superfused for 10 min from S 1 onwards, strongly potentiated the effect of ATP at S 3 (903.1 ± 206.2%, n = 4, P < 0.05). In the following experiments, ATP (3000 lM) was applied 5 times according to the usual time schedule in the low X 2+ external medium. Under these conditions, the ATP-induced current amplitudes decreased to 82.8 ± 4.1% (n = 6, P < 0.05) from S 1 to S 3 . Both PPADS (30 lM; 20.4 ± 8.4%, n = 5) and BBG (1 lM; 40.4 ± 14.9%, n = 6, P < 0.05 each) inhibited the effect of ATP.
Reversal Potential of BzATP-and ATP-Induced Currents in Astroglial Cells of the Rat PFC; Isolation of Individual Astroglial Cells by Pharmacological Methods or by Preparing Excised Patches
To construct a current--voltage curve for the BzATP (300 lM) current and to assess the reversal potential, we applied the agonist for 10 s, with 5 min intervals, at the holding potentials of --90, --60, --30, 0, and 30 mV (Fig. 5A ). The resulting I/V relationship was linear in the range studied and crossed the voltage axis at --1.5 ± 3.7 mV (n = 4), indicating a nonselective cationic conductance increase.
In the following experiments, we investigated whether the effect of BzATP arises at P2X 7 receptors located at the patched astroglial cells themselves or whether these receptors are located at neighboring cells releasing glutamate, the main excitatory transmitter of the brain. In fact, an inhibitory cocktail consisting of tetrodotoxin (0.5 lM), DL-2-amino-5-phosphonopentanoic acid (DL-AP-5; 50 lM), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 lM), AIDA (300 lM), (RS)-APICA (300 lM), and UBP1112 (100 lM) was applied to block sodium-dependent action potentials, as well as a range of ionotropic and metabotropic glutamate receptors. Under these conditions, the BzATP (300 lM)-induced current response was not altered when compared with the spontaneous decrease from S 1 to S 3 in the absence of antagonists ( Fig. 4Ac ; compare the first with the second column).
Then, excised patches were prepared by slowly withdrawing the pipette to terminate the whole-cell recording condition and separate the excised patch from the surrounding cells (see Materials and Methods). The BzATP (300 lM) current measured in the usual whole-cell mode was 365.7 ± 76.0 pA before and 76.0 ± 51.7 pA (24.4 ± 0.1%, n = 4, P < 0.05) after withdrawing the pipette. Thus, the excised astroglial membrane was still able to react to BzATP, although with a decreased current amplitude. This may be due to the lower number of receptor channels available for activation. Eventually, the IR for P2X 7 receptors was clearly colocalized with the astroglial marker S100 on a cell labeled during recording with LY ( Fig. 5Ca--d) . It is evident that in this cell, the withdrawal of the pipette inflicted a marked damage to the cell body. (Fig. 6Ab,Ac) . These results are in agreement with data obtained in Wistar rats (Fig. 6Aa) . By contrast, in Tg(GFAP/EGFP) mice, only PA cells were found (Fig. 6Ad) . We are convinced that ORAs were not overlooked in the transgenic animals because all cells exhibited sponge-like heavily branched nets of processes, typical for PAs (GluTs in the terminology of Matthias et al. 2003) . Since there were no imminent differences between the VRA and PA characteristics within a certain line of mice, we pooled the V m , C m , and R m values for these animals (Supplementary Table 1 ). We found that the membrane parameters of P2X 7 -/-and Tg(GFAP/GFP) astroglia did not differ from the analogous parameters of C57BL6 cells.
Comparison of ATP-and BzATP-Induced Currents in
The application of NMDA (100 lM) for 10 s evoked inward currents, which were considerably larger in all strains of mice (C57BL6, --723.4 ± 108.5 pA, n = 9; P2X 7 -/-, --615.4 ± 109.9 pA, n = 10; Tg(GFAP/EGFP), --578.0 ± 58.4 pA, n = 5; P < 0.05 each) (Fig. 6Ca--c , left outer panel) than those measured in rats (--176.8 ± 27.2 pA, n = 30, P < 0.05). By contrast, the concentration--response curves of ATP (100--30 000 lM) were shallower in mice (I max = --665.5 ± 18.8 pA, EC 50 = 2728.2 ± 215.1 lM, n = 9) than in rats (I max = --1150.4 ± 314.6 pA, EC 50 = 10 801.1 ± 3 680.2 lM, n = 7) (Fig. 6B) . Astroglial cells of C57BL6, P2X 7 -/-, and Tg(GFAP/EGFP) mice failed to react to BzATP (300 lM) in a normal aCSF (Fig. 6Cc, left inner panel) . However, in a low X 2+ aCSF, astroglia of C57BL6 mice responded both to BzATP (300 lM; --139.3 ± 59.8, n = 6) and ATP (3000 lM; --229.1 ± 60.7 pA, n = 9) (Fig. 6Ca ,Cc, right 2 panels) with inward currents, whereas their counterparts from the P2X 7 -/-animals were completely insensitive to these agonists (BzATP, --15.8 ± 13.7 pA, n = 8; ATP, --3.9 ± 11.3 pA, n = 10; P < 0.05 each) (Fig. 6Ca ,Cc, right 2 panels). Eventually, ATP caused only a slight response in Tg(GFAP/EGFP) astroglial cells (Fig. 6Cb ,Cc, right outer panel). (10 min) either in the absence (gray trace) or in the presence of PPADS (30 lM), DPCPX, or low X 2þ aCSF (red traces each) onto the same cell. ATP was applied repetitively both in low X 2þ aCSF (Ba) and normal aCSF (Bb). (Bc) Normalized mean ± standard error of the mean values of ATP responses after 10 min of superfusion with normal aCSF (control; empty column), DPCPX (0.1 lM; black column), and low X 2þ aCSF (gray column) (left set of columns). Normalized mean ± standard error of the mean values of ATP responses in low X 2þ aCSF (control; empty column) or after 10 min of additional superfusion with PPADS (30 lM; black column) or BBG (gray column) (right set of columns). *P \ 0.05; statistically significant difference from the control ATP value at 0 min in a normal aCSF. **P \ 0.05; statistically significant difference from the control ATP value at 0 min in a low X 2þ aCSF.
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Effect of ATP/BzATP on Excitatory Postsynaptic Currents Measured in Pyramidal Neurons of the Rodent PFC
In further experiments, we evoked EPSCs in layer V pyramidal neurons of Wistar rats by electrical stimulation in the layer I/II of prefrontal cortical brain slices. These neurons were easily differentiated from astroglial cells both by their shape and by their diameter (see above). In addition, the injection of depolarizing current pulses above a certain threshold elicited action potential firing ( Supplementary Fig. 1Cb ). We never observed in any of the pyramidal cells spontaneous EPSCs either before or after the application of BzATP (300 lM; Fig. 7A ). Superfusion with AP-5 (50 lM) and NBQX (10 lM) for 10 min abolished the evoked EPSCs (n = 5), thereby identifying the neurotransmitter involved as glutamate. The application of BzATP (300 lM) for 5 min did not alter the inward holding current in these neurons (Fig. 7A ,Bc) but massively depressed the EPSC amplitudes (--129.7 ± 38.3 pA in the absence and --63.7 ± 12.5 pA in the presence of BzATP, n = 7, P < 0.05; Fig. 7Ba ,Bc). Preincubation with the selective metabolic inhibitor of astroglial cells, fluoroacetic acid (100 lM; 50.7 ± 6.8% inhibition of the EPSCs by BzATP, n = 7) or the application of the P2X 7 receptor antagonist A 438079 (1 lM; 40.6 ± 6.5% inhibition by BzATP, n = 7; P > 0.05 each) failed to alter the effect of BzATP determined under control conditions (300 lM;
42.7 ± 9.1% inhibition, n = 9) (Fig. 7Bd ,Be,Bf). By contrast, DPCPX (0.1 lM; 6.6 ± 4.1% inhibition of the EPSCs by BzATP, n = 9, P < 0.05 vs. control) abolished the blockade by BzATP of the EPSC amplitudes (Fig. 7Bb ,Be,Bf). When given alone, DPCPX potentiated the amplitudes of the excitatory synaptic currents (by 28.2 ± 6.9%, n = 9, P < 0.05), whereas A 438079 (8.7 ± 8.2%, n = 9, P > 0.05) had no statistically significant effect (Fig. 7Be) . The application of aCSF for 5 min with the same pressure as that used for drug application failed to alter the EPSCs (Fig. 7Bd,Bf) . In conclusion, BzATP strongly depressed the EPSC amplitudes via the occupation of neuronal adenosine A1 receptors rather than by activating astroglial P2X 7 receptors. We suggest, in accordance with Kukley et al. (2004) , who reported similar findings for hippocampal mossy fiber-CA3 synapses, that this effect is due to the displacement of adenosine from its storage sites by Bz-adenosine generated from BzATP by enzymatic degradation. The reasons for this suggestion were that on the one hand Bz-adenosine is only a weak A 1 receptor agonist (Klotz 2000) and on the other hand adenosine deaminase, breaking down Bz-adenosine to Bz-inosine abolished the effect of Bz-ATP on EPSCs. Moreover, inosine, competing with adenosine (Bz-adenosine) at the nucleoside transporter, also interacted with the Bz-ATP--induced inhibition of EPSCs. Thus, nucleoside transporters were supposed to heteroexchange extracellular Bz-adenosine for adenosine from intracellular sources.
Effects of BzATP and ATP on Astroglial Cells of the Rat
Oriens Layer and Their Interaction with P2X 7 Receptor Antagonists Whereas in the rat PFC LY diffusing from the patch pipette usually failed to label astroglial cells other than those from which we recorded electrophysiologically (see Results), in the oriens layer, there was a labeling of numerous cells in every brain slice. In partial contradiction with experiments in the rat and mouse PFC, astroglia of the rat oriens layer expressed only VRAs and PAs but no ORAs (Fig. 8A) . Furthermore, the very small current responses caused by both BzATP (300 lM; --43.0 ± 4.2 pA) and ATP (3000 lM; --89.5 ± 13.8 pA) in a normal aCSF, largely increased in a low X 2+ aCSF (BzATP, --840.9 ± 108.8 pA, n = 6, P < 0.05; ATP, --751.9 ± 224.2 pA, n = 5, P < 0.05) (Fig. 8Ba,Bb) . In a low X 2+ aCSF, BzATP (10--3000 lM) and ATP (300--30 000 lM) both caused concentration-dependent inward currents (Fig. 8Ca,Cb) . Although the concentration--response curve of ATP did not reach a maximum even at 30 000 lM, it is quite clear that BzATP (I max = --1712.3 ± 38.2 pA, EC 50 = --146.8 pA, n = 8) is much more potent under these conditions than ATP itself. Eventually, the P2X 7 receptor antagonist A 438079 depressed the effect of BzATP (300 lM) at 1 lM and almost abolished it at 10 lM (15.2 ± 7.9%, n = 4; Fig.   8Da ,Db). By contrast, a rather high concentration of A 438079 only moderately depressed the effect of NMDA (100 lM) indicating selectivity for P2X 7 over NMDA receptors in astroglia.
Discussion
The main message of this paper is that morphologically, immunohistochemically, and electrophysiologically identified astroglial cells in brain slice preparations are endowed with both NMDA and P2X 7 receptors, which are present in all types of astroglia, independent of their voltage--current characteristics À/À (Ac), and Tg(GFAP/EGFP) (Ad) mice. (B) Concentration--response curves for ATP (100--30 000 lM) for 10 s with an interval of 5 min, in a low X 2þ aCSF in rat (empty squares) and C57BI6 mouse (empty circles) astroglia (n 5 6--7). The data for the rat astroglia were replotted from Figure 3Cc . Representative recordings of astroglial current responses to 10-s local application of NMDA (100 lM; normal aCSF) and ATP (3000 lM; low X 2þ aCSF). P2X 7 À/À mice (Ca, gray tracings), their wild-type backgrounds (Ca, C57Bl6, black tracings), and Tg(GFAP/EGFP) (Cb, black tracings) were used. (Cc) Summary of current amplitudes in rat (empty), wild-type (C57Bl6; light gray), P2X 7 À/À (gray), and Tg(GFAP/EGFP) mice (black), after the local application of NMDA (100 lM; outer left panel) and BzATP (300 lM; inner left panel) in normal aCSF, as well as BzATP (300 lM; inner right panel), and ATP (3000 lM; outer right panel) in low X 2þ aCSF. The number of cells is indicated within the respective columns; *P \ 0.05; statistically significant difference from results obtained in rat astroglia. **P \ 0.05; statistically significant difference from results in C57BI6 mice.
Cerebral Cortex April 2011, V 21 N 4 815 (ORA, VRA, or PA). Our findings basically confirm the data reported both for hippocampal astroglial cells of rats (Zhou and Kimelberg 2001; Zhou et al. 2006 ) and transgenic mice with GFAP promoter--controlled EGFP expression (Matthias et al. 2003; Grass et al. 2004; Jabs et al. 2007 ), although we did not find ORAs in the PFC of Tg(GFAP/EGFP) mice and the oriens layer of rats. This may be due to the different area of the brain investigated by us.
A more detailed immunohistochemical search for P2X 7 receptors showed that LY-filled astroglial cells but not neurons express this receptor type, and both GFAP-and S100-labeled cells exhibit P2X 7 -IR. Our results are in agreement with previous in vivo work, demonstrating the expression of P2X 7 receptors in the brain, especially after mechanical or ischemic damage (Franke et al. 2001 (Franke et al. , 2004 . The presence of P2X 7 receptor IR was also repeatedly described in cultured and acutely dissociated astroglial cells, for example, from the cerebral cortex (Jacques-Silva et al. 2004) or hippocampus (Panenka et al. 2001) .
In the present experiments, the P2X 1,7 preferring agonist BzATP and the general P2X receptor agonist ATP both induced rapid inward currents in astroglial cells held at --80 mV. These (A) Current responses to a series of voltage steps from --160 to þ70 mV (10 mV steps for 500 ms) were recorded from astroglial cells, which were classified according to 3 types of I/V patterns as VRA and PA. ORA cells were completely missing. (B) BzATP (300 lM) or ATP (3000 lM) were applied twice in a normal aCSF and subsequently again twice in a low X 2þ aCSF. Agonist superfusion times were in 10 s in all cases (B--D). Representative recording of the ATP effect (Ba) and current amplitudes in response to BzATP and ATP before and after the reduction of divalent cations in the external medium (Bb). The mean ± standard error of the mean of the second and fourth response to the P2 receptor agonists was evaluated of a series of 4 applications (n 5 5--6 as indicated). (C) Current responses to increasing concentrations of BzATP (10--3000 lM) and ATP (300--30 000 lM) in a low X 2þ aCSF. Representative recording of the BzATP effect (Ca). Concentration--response relationships of BzATP (empty circles) and ATP (empty squares) (Cb; n 5 6--8). (D) BzATP (300 lM) or NMDA (100 lM) were applied 6 times, before, during, and after superfusion with A 438079 (10 lM). Representative recording of the interaction between A 438079 and BzATP (Da). Concentration-dependent inhibition of the BzATP effect by A 438079 and interaction of NMDA with the P2X 7 receptor antagonist (Db). Mean ± standard error of the mean of the agonist-induced current in the presence of A 438079 measured at 15 min, normalized with respect to the current measured at 5 min, after starting the application protocol (n 5 4--6). *P \ 0.05; statistically significant difference from the second agonist application (Bb) or from the fourth agonist application in the absence of the antagonist (time-matching controls; Db).
Cerebral Cortex April 2011, V 21 N 4 817 results agree with the electrophysiologically confirmed presence of P2X 7 receptors in cultured cortical astroglia of rats (Walz et al. 1994 ) and mice (Duan et al. 2003) . They also comply with Ca 2+ imaging data, supporting the existence of P2X 7 receptors in rat-cultured cortical astroglial cells (Ballerini et al. 1996; Fumagalli et al. 2003) .
A whole range of data strongly suggests that the BzATP and ATP currents recorded by us in brain slices are due to the activation of astroglial P2X 7 receptors. 1) The P2X 1,7 agonist BzATP was effective in contrast to the P2X 1,3 agonist a,b-meATP, which identifies the P2X 7 receptor type as a drug target. 2) Both ATP and its enzymatically stable analogue ATPc-S did not act in the micromolar range, but ATP became active at millimolar concentrations, which conforms with the fact that BzATP is 10--30 times more potent at P2X 7 receptors than ATP itself (Sperla´gh et al. 2006; Anderson and Nedergaard 2006) . Moreover, in a low divalent cation--containing medium, the concentration--response curves for both BzATP and ATP were shifted to the left and their maxima showed a corresponding increase. The inverse dependence of the P2X 7 receptor current amplitudes on the external divalent cation concentration has been known for many decades (Jiang 2009). 3) The general P2X/P2Y antagonist PPADS, just as the selective P2X 7 receptor antagonists BBG, A 438079 and calmidazolium counteracted the effects of BzATP and ATP. However, none of these antagonists abolished the agonist effects even at concentrations that considerably surmount their dissociation equilibrium constants at recombinant P2X 7 receptors (North 2002; Jarvis and Khakh 2009) . The reason for this may be either that the splice variant of P2X 7 receptors (Cheewatrakoolpong et al. 2005; Nicke et al. 2009 ) probably present in cortical astroglial cells has an antagonist-binding site slightly different from that of the recombinant subunit or that the strongly negatively charged dyes PPADS, BBG, and A 438079 have to pass in the brain slice diffusion barriers to reach the receptor, and during this process, large quantities of these antagonists are bound to positively charged proteins (Tal et al. 1985) . 4) Although the BzATP-or ATP-induced current reversed near 0 mV and was, thereby, certainly due to the opening of P2X receptor channels, the P2X 1--4 receptor antagonist TNP-ATP or the positive allosteric modulator of P2X 4 receptors, ivermectin failed to modulate the BzATP effect, excluding the involvement of these receptor types. Hence, in conclusion, up to this point, all data as a whole unequivocally support the involvement of P2X 7 receptors.
Additional evidence for the existence of astroglial P2X 7 receptors was supplied by the use of P2X 7 -/-mice and their wild-type controls. BzATP and ATP caused inward current in a low X 2+ medium in the control, but not knockout mice, although the astroglia from both lines of animals were equally responsive to NMDA. Our reason for using NMDA as a reference agonist was that every astroglial cell investigated was sensitive to NMDA, irrespective of whether the brain slice preparation was obtained from rats or mice and whether it was superfused with a normal or low X 2+ aCSF. In contrast to neuronal NMDA receptors, their astroglial counterparts were shown not to be affected by extracellular Mg 2+ (Lalo et al. 2006; Verkhratsky and Kirchhoff 2007) .
The concentration--response curves of ATP in a low X 2+ aCSF showed that in rat astroglial cells, the agonist-induced currents were much larger than in the C57BI6 mouse astroglia. In Tg(GFAP/EGFP) mice, which were bred on the background 14Mes/J, BzATP did not act in a normal aCSF, and the effects of BzATP and ATP were still very low in spite of decreasing the Ca 2+ concentration and omitting Mg 2+ from the extracellular medium. These results perfectly agree with the reported data that both BzATP and ATP activate the recombinant mouse P2X 7 receptor with much lower potencies than the corresponding rat receptor (Young et al. 2007 ). The agonist EC 50 values were determined solely by differences in the amino acid composition of the ectodomains of these receptors.
Experiments in Tg(GFAP/EGFP) mice are particularly interesting because it was reported that in hippocampal brain slices of such animals, neither BzATP-nor ATP-induced P2X 7 receptor--mediated inward currents of astroglial cells (Jabs et al. 2007 ). However, the ATP sensitivity of the astroglia from wild-type mice and especially from the transgenic animals was very low also in our hands, in contrast to their normal sensitivity toward NMDA. Thus, this strain of mice is apparently not an appropriate model to search for any P2X receptor--mediated current responses. Moreover, when astroglial cells were acutely dissociated from the cerebral cortex of these mice, P2X 1/5 rather than P2X 7 receptors could be identified both by electrophysiology and by reverse transcription-polymerase chain reaction (Lalo et al. 2008) . In this latter case, an additional complicating factor may be the reported ability of P2X 7 receptors to interact with several cytoskeletal proteins including actin (Sperla´gh et al. 2006; Surprenant and North 2009 ). Actin filament disintegration, such as that occurring during the mechanical dissociation, may influence the activity of these receptors, potentially by impeding their assembly from monomers into the operative trimeric configuration (Li et al. 2003) .
A potential point of criticism may be that whereas we studied astroglia of the rat PFC, Jabs et al. (2007) found an insensitivity of this cell type in the CA1 area of the rat hippocampus. Therefore, we decided to patch astroglia in the oriens layer near the border of the CA1 region of the hippocampus. These cells may be identical in their physiological and pharmacological characteristics to their CA1 counterparts but are much easier to locate. Astroglia of the rat oriens layer belonged to the VRA and PA classes. Both BzATP-and ATP-induced small inward currents, which markedly increased in a low X 2+ medium. In addition, the current responses to BzATP were depressed by the highly selective P2X 7 receptor antagonist A 438079. These results as a whole suggest that rodent astroglial cells of various brain regions (layer V of the PFC, oriens layer besides the hippocampal CA1 area) are equally endowed with P2X 7 receptors.
Eventually, the question arises, whether the stimulation of astroglial P2X 7 receptors leads to the release of a signaling molecule that might modulate the activity of neighboring pyramidal neurons. P2X 7 receptor activation in astroglia has been reported to release glutamate (Duan et al. 2003; Fellin et al. 2006 ) and ATP itself (Suadicani et al. 2006) . In fact, BzATP has been reported to trigger 2 different glutamate-mediated responses in CA1 pyramidal neurons of the rat hippocampus. These were 1) transient inward currents due to a calcium dependent but P2X 7 receptor--independent exocytotic glutamate release from astroglial cells and 2) a sustained tonic current also due to glutamate release but dependent on P2X 7 receptor activation (Fellin et al. 2006) . However, at least in the rat PFC, there was no indication for any effect of BzATP application on EPSC amplitudes (recorded in layer V and evoked by electrical stimulation in layer I/II), other than a marked, and DPCPX reversible decrease (Fig. 7Be) . We suggest that this effect is due to the displacement of adenosine from its storage sites by Bz-adenosine generated from BzATP by enzymatic degradation (for hippocampal mossy fibre-CA3 synapses, see Kukley et al. 2004 ).
In conclusion, when astroglial cells are prepared with minimal mechanical damage and left in the integrated network of the neighboring astroglia and neurons in rodent prefrontal cortical or hippocampal slices, they exhibit BzATP-and ATPsensitive P2X 7 receptors. These receptors fail to interact with pyramidal neurons via glutamate or any other short-term signaling molecule but may be targets of the massive outflow of ATP initiated by any type of cerebrocortical injury. In consequence, they are supposed to mediate necrosis/apoptosis in the short term and astrogliosis in the long term, both aggravating the immediate neuronal damage.
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